Form D — Belhaven Biopharma Inc.
0001231919-25-000318 · filed 2025-10-15
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $32,289,627
- Total sold
- $32,289,627
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Belhaven Biopharma Inc.
- CIK
- 1873965
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 84406 Winslow
Chapel Hill, NC 27517 - Phone
- 919-656-8658
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Scott David Lyman · Executive OfficerChapel Hill, NC Find on LinkedIn ↗
-
David Algon Neal · Executive OfficerChapel Hill, NC Find on LinkedIn ↗
-
Wes Wheeler · DirectorChapel Hill, NC Find on LinkedIn ↗
-
Derek Winstanly · DirectorChapel Hill, NC Find on LinkedIn ↗
View original on SEC EDGAR.